Filter Results:
(7,889)
Show Results For
- All HBS Web
(7,889)
- People (21)
- News (2,650)
- Research (4,140)
- Events (21)
- Multimedia (297)
- Faculty Publications (3,379)
Show Results For
- All HBS Web
(7,889)
- People (21)
- News (2,650)
- Research (4,140)
- Events (21)
- Multimedia (297)
- Faculty Publications (3,379)
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
forced that company into bankruptcy. The acquisition further strengthened American Home Products's new animal health unit and its established prescription drug line. In 1987, predating the Robbins transaction and the sale of the... View Details
- 30 Aug 2021
- News
One and the Same
working for McKinsey in London and New York; most recently, she served as MP for the Victorian Parliament from 2006 to 2020, in addition to roles as Victoria’s Minister for Mental Health and Community Services and Minister for Women’s... View Details
- November 2004
- Case
Technology Commercialization at the Massachusetts General Hospital
The Department of Corporate Sponsored Research & Licensing (CSRL) at the Massachusetts General Hospital (MGH) serves as the primary interface between the hospital and the private sector. Examines the range of issues related to the commercialization of MGH's... View Details
Keywords: Technological Innovation; Conflict of Interests; Commercialization; Higher Education; Health Care and Treatment; Health Industry; Health Industry; Massachusetts
West, Jonathan, and Mona Ashiya. "Technology Commercialization at the Massachusetts General Hospital." Harvard Business School Case 605-049, November 2004.
- 2008
- Other Unpublished Work
Evidence-Based Medicine and the Changing Nature of Healthcare: 2007 IOM Annual Meeting Summary
Keywords: Health
Porter, Michael E. "Evidence-Based Medicine and the Changing Nature of Healthcare: 2007 IOM Annual Meeting Summary." Institute of Medicine, Washington, DC, October 2008.
- April 2009 (Revised April 2010)
- Supplement
Merck: Managing Vioxx (F)
By: Robert L. Simons and Natalie Kindred
Simons, Robert L., and Natalie Kindred. "Merck: Managing Vioxx (F)." Harvard Business School Supplement 109-085, April 2009. (Revised April 2010.)
- April 2009 (Revised April 2010)
- Supplement
Merck: Managing Vioxx (B)
By: Robert L. Simons, Kathryn Rosenberg and Natalie Kindred
Simons, Robert L., Kathryn Rosenberg, and Natalie Kindred. "Merck: Managing Vioxx (B)." Harvard Business School Supplement 109-081, April 2009. (Revised April 2010.)
- March 28, 2005
- Article
Uncle Sam Is No Doctor
Keywords: Health
Herzlinger, Regina E. "Uncle Sam Is No Doctor." USA Today ( March 28, 2005).
- May 2005
- Article
A Kidney Exchange Clearinghouse in New England
By: Alvin E Roth, Tayfun Sonmez and M. Utku Unver
Keywords: Health
Roth, Alvin E., Tayfun Sonmez, and M. Utku Unver. "A Kidney Exchange Clearinghouse in New England." American Economic Review 95, no. 2 (May 2005): 376–380.
- 1997
- Article
Is Absorption a Diathesis for Dissociation in Sexually and Physically Abused Patients?
By: R. G. Kunzendorf, D. M. Hulihan, W. Simpson, N. Pritykina and K. Williams
Keywords: Health
- 01 Sep 2018
- News
Case Study: A Good Fit
corporate wellness market by partnering with health plans and employers, and has expanded into more general health and wellness areas, with apps for people who want to eat better, for instance, or be more... View Details
Keywords: Jen McFarland Flint
- Profile
Nabihah Sachedina
program director of the London Health Commission, an independent review panel backed by the city's mayor, to "look at care in the capital, and how to improve the health of Londoners." "It... View Details
- Web
Institute Associates - Institute For Strategy And Competitiveness
Austin. He is a nationally recognized leader in orthopaedic surgery and value-based health care payment and delivery models. Prior to joining the Dell Medical School, he was the William R. Murray Endowed Professor and Vice Chair of... View Details
- 16 Oct 2013
- Op-Ed
Response to Readers: Combating Climate Change with Nuclear Power and Fracking
With more than 7,500 views and 180-plus tweets, I want to thank everyone for taking the time to read the original HBS Working Knowledge piece, The Case for Combating Climate Change with Nuclear Power and Fracking, and, in particular, for sharing your thoughts with one... View Details
- 18 Apr 2019
- News
Open Innovation Contestants Build AI-Based Cancer Tool
- 25 Aug 2015
- Blog Post
Why an MD/MBA from HBS and HMS?
It is not uncommon for me to be asked, "So, what do you want to do when you grow up?” In response, I usually respond, "I want to change health care." Anyone who knows me will understand my penchant for exaggeration, but... View Details
- August 2021
- Teaching Note
IBM Watson at MD Anderson Cancer Center
By: Shane Greenstein and Mel Martin
Teaching Note for HBS Case No. 621-022. View Details
Keywords: Decision Making; Technological Innovation; Innovation Strategy; Knowledge Management; Knowledge Use and Leverage; Operations; Failure; Information Technology; Applications and Software; Health Care and Treatment; Product Development; Health Industry; Health Industry; Health Industry; United States; Houston; Texas
- 11 Jun 2020
- In Practice
Are Digital Organizations Better at Overcoming COVID?
provided but to augment and expand their offerings. Telemedicine is a terrific example of this. Many health care providers have already moved to virtual visits and ramped up new types of services such as remote-patient monitoring using... View Details
Keywords: by Danielle Kost
- January 2021
- Case
mPharma (A)
By: Rembrand Koning, John D. Macomber, Pippa Tubman Armerding and Wale Lawal
mPharma pioneered electronic prescriptions in Ghana, and aimed to increase drug affordability and accessibility in Africa, but the company remained unprofitable. Following investor concerns about mPharma's business, CEO Gregory Rockson considered alternative business... View Details
Keywords: Strategy; Entrepreneurship; Acquisition; Health; Business Model; Health Industry; Health Industry; Ghana
Koning, Rembrand, John D. Macomber, Pippa Tubman Armerding, and Wale Lawal. "mPharma (A)." Harvard Business School Case 721-428, January 2021.
- Article
The Case for a COVID Vaccine Lottery
By: Scott Duke Kominers and Alex Tabarrok
Even the smartest distribution plans are complicated by a stubborn fact: We won't have enough for everyone right away. View Details
Kominers, Scott Duke, and Alex Tabarrok. "The Case for a COVID Vaccine Lottery." Bloomberg Opinion (November 9, 2020).
- November 2012
- Supplement
Amylin Pharmaceuticals (B)
By: Richard G. Hamermesh and Carin-Isabel Knoop
Amylin Pharmaceuticals brought two first-in-class diabetes drugs to market, Byetta and Symlin, in 2005, which were sold in over 80 countries with $650.7 million in sales by 2011. However, the company remained unprofitable as sales plateaued. The small pharmaceutical... View Details
Keywords: Pharmaceuticals; Bristol-Myers Squibb; Health Care and Treatment; Pharmaceutical Industry; United States
Hamermesh, Richard G., and Carin-Isabel Knoop. "Amylin Pharmaceuticals (B)." Harvard Business School Supplement 813-091, November 2012.